In conclusion, these findings suggest that the suppression of IGF2BP3 in colon cancer cells drives ferroptosis through the modulation of SLC7A11 mRNA stability, consequently increasing the susceptibility to ferroptosis. Here, IGF2BP3 is linked to malignant colon neoplasm.